OpenAlex
PricingAboutJobs
Log inGet started
Work

Abstract C63: Biological characterization of GSK2126458, a novel and potent inhibitor of phosphoinositide 3-kinase and the mammalian target of rapamycin (mTOR)

HTML

Year: 2009
Type: conference-abstract
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.targ-09-c63
Authors: Mary Ann Hardwicke, Hong Lu, Lusong Luo, Melody Diamond, Chiu-Mei Sung, Jeffrey D. Carson, Ramona Plant, Christine Gardiner, Jamin Wang, Catherine A. Oleykowski, Richard Gontarek, Glenn Van Aller, Seth Gilbert, David S. Sutton, Peter J. Tummino, Richard F. Wooster, Steven D. Knight, Jeffrey R. Jackson, Dashyant Dhanak, Kurt R. Auger
Institution: GlaxoSmithKline (United States)
Language: English

Topic: PI3K/AKT/mTOR signaling in cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: GSK2126458, PI3K inhibitors, mTOR inhibition, PI3K signaling, Akt phosphorylation, apoptosis, caspase-3/7 activation, breast cancer xenografts, tumor growth inhibition
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2014865890
Cites:
Cited by: 1
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security